PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
The Cedrus genus is associated with cytotoxic, spasmolytic, immunomodulatory, antiallergic, anti-inflammatory, analgesic, antibacterial, and antiviral activities, though further clinical trials are required [PMID: 28670915]
Evidence summary
PubMed sources
- 1.PMID: 21583133 (2009) — N-[4-Acetyl-5-(2-methylprop-1-enyl)-5-(2-p-tolyl-prop-yl)-4,5-dihydro-1,3,4-thia-diazol-2-yl]acetamide. · Acta crystallographica. Section E, Structure reports online
- 2.PMID: 24826147 (2014) — 1-[(1S,6R,7S,9R)-8,8-Di-bromo-5,5,9-tri-methyl-tri-cyclo-[4.4.0.1(7,9)]decan-1-yl]ethanone. · Acta crystallographica. Section E, Structure reports online
- 3.PMID: 24860392 (2014) — (1S,2R,3S,6S,7R)-3,7,11,11-Tetra-methyl-6,7-epoxybi-cyclo-[5.4.0]undecane-2-ol. · Acta crystallographica. Section E, Structure reports online
- 4.PMID: 24860339 (2014) — (1R,4R,6S,7R)-5,5-Di-bromo-1,4,8,8-tetra-methyl-tri-cyclo-[5.4.1.0(4,6)]dodecan-12-one. · Acta crystallographica. Section E, Structure reports online
- 5.PMID: 23476222